BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Feb 9 Shinil Pharmaceutical Co Ltd :
* Says it plans to pay annual cash dividend as 140 won/share for FY 2016, to shareholders of record on Dec. 31, 2016
* Total dividend amount is 1.05 billion won
Source text in Korean: goo.gl/OTd46j
Further company coverage: (Beijing Headline News)
WASHINGTON, March 28 U.S. President Donald Trump told a group of senators on Tuesday that he expected lawmakers would be able to reach a deal on healthcare, without offering specifics on how they would do it or what had changed since a healthcare reform bill was pulled last week for insufficient support.